164 related articles for article (PubMed ID: 16775432)
1. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
Zhang Q; Chen X; Zhou J; Zhang L; Zhao Q; Chen G; Xu J; Qian F; Chen Z
Cancer Biol Ther; 2006 Jul; 5(7):808-14. PubMed ID: 16775432
[TBL] [Abstract][Full Text] [Related]
2. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
Wang Y; Zhang XH; Guo P; Yan LN; He D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
[TBL] [Abstract][Full Text] [Related]
3. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
[TBL] [Abstract][Full Text] [Related]
5. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.
Poon RT; Ng IO; Lau C; Yu WC; Yang ZF; Fan ST; Wong J
J Clin Oncol; 2002 Apr; 20(7):1775-85. PubMed ID: 11919234
[TBL] [Abstract][Full Text] [Related]
6. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
[TBL] [Abstract][Full Text] [Related]
7. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.
Salizzoni M; Romagnoli R; Lupo F; David E; Mirabella S; Cerutti E; Ottobrelli A
Transplantation; 2003 Sep; 76(5):844-8. PubMed ID: 14501865
[TBL] [Abstract][Full Text] [Related]
8. The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
Chen ZB; Shen SQ; Ding YM; Wang WX; Tao JP; Liang LJ; Hu WJ
Med Oncol; 2009; 26(3):365-71. PubMed ID: 19082771
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinase 1 as a Novel Biomarker for Monitoring Hepatocellular Carcinoma in Liver Transplant Patients.
Sánchez-Lorencio MI; Saenz L; Ramirez P; Villalba-López F; de la Orden V; Mediero-Valeros B; Revilla Nuin B; Gonzalez MR; Cascales-Campos PA; Ferreras-Martínez D; Noguera-Velasco JA; Díaz-Rubio E; Parrilla P
Transplant Proc; 2018 Mar; 50(2):623-627. PubMed ID: 29579870
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
16. Expression of Fibrogenic Markers in Tumor and Tumor-Surrounding Tissue at Time of Transplantation Correlates with Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation.
Kocabayoglu P; Piras-Straub K; Gerken G; Paul A; Herzer K
Ann Transplant; 2017 Jul; 22():446-454. PubMed ID: 28729525
[TBL] [Abstract][Full Text] [Related]
17. Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
Sun MH; Han XC; Jia MK; Jiang WD; Wang M; Zhang H; Han G; Jiang Y
World J Gastroenterol; 2005 Oct; 11(38):5931-7. PubMed ID: 16273602
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
[TBL] [Abstract][Full Text] [Related]
20. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.
Wu J; Hao ZW; Zhao YX; Yang XM; Tang H; Zhang X; Song F; Sun XX; Wang B; Nan G; Chen ZN; Bian H
J Transl Med; 2014 Jul; 12():190. PubMed ID: 24996644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
